Boston Scientific Corporation (BSX) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Boston Scientific Corporation (BSX:NYSE), powered by AI.

Current Price
$46.91
P/E Ratio
24.0
Market Cap
69.4B
Sector
Healthcare
What is the Boston Scientific Corporation stock price forecast?

Boston Scientific Corporation is currently trading at $46.91. View real-time AI analysis on Alpha Lenz.

What is Boston Scientific Corporation insider trading activity?

View the latest insider trading data for Boston Scientific Corporation on Alpha Lenz.

What is Boston Scientific Corporation's P/E ratio?

Boston Scientific Corporation's P/E ratio is 24.0.

Boston Scientific Corporation

NYSE · BSX
$46.91-0.26(-0.55%)Pre-marketNYSE regular session 09:30–16:00 ET
Ask about Boston Scientific Corporation's future dividend policy...
Alpha Chat Insight

Boston Scientific Corporation trades at a P/E of 24.0 (fair value) with solid ROE of 12.6%. 3Y revenue CAGR of 16.5% highlights clear growth momentum.

Ask for details

Company Overview

Boston Scientific Corporation, a leading global medical device company, is renowned for developing and supplying innovative health solutions. Its primary function is to design, manufacture, and market medical devices used in interventional medical specialties such as cardiology, peripheral interventions, cardiac rhythm management, endoscopy, urology, and neuromodulation. The company's product offerings significantly impact sectors like health care, particularly those focusing on minimally invasive treatments. Boston Scientific's products help improve the quality of patient care and reduce the need for major surgery, thus playing a crucial role in modern healthcare systems. Their devices contribute to procedures that are less invasive, more effective, and often more economic, supporting better patient outcomes and quicker recovery times. Founded in 1979 and headquartered in Marlborough, Massachusetts, Boston Scientific provides its products to healthcare providers and institutions worldwide. In the financial markets, Boston Scientific Corporation holds significant influence as a major player in the healthcare industry, contributing to advancements in medical technology and shaping the future of patient care through research and development. Its presence underscores the importance of innovation in medical devices and its role in enhancing healthcare delivery.

CEOMr. Michael F. Mahoney
SectorHealthcare
IndustryMedical Devices
Employees53,000

Company Statistics

FY 2025

Profile

$69.45BMarket Cap
$20.07BRevenue
0.00Shares Out
53,000Employees

Margins

69.01%Gross
26.57%EBITDA
19.78%Operating
16.86%Pre-Tax
14.41%Net

Valuation

23.96P/E
2.87P/B
3.46EV/Sales
14.84EV/EBITDA
20.40P/FCF

Growth (CAGR)

16.54%Rev 3Yr
15.16%Rev 5Yr
25.00%Op Inc 3Yr
42.16%Op Inc 5Yr
60.61%Net Inc 3Yr
N/ANet Inc 5Yr

Returns

6.96%ROA
12.60%ROE
8.99%ROIC

Financial Health

$1.97BCash & Cash Equivalents
$17.24BNet Debt
78.46%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Boston Scientific Corporation (ticker: BSX) is a company listed on NYSE in the Healthcare sector (Medical Devices). It has approximately 53,000 employees. Market cap is $69.4B.

The current price is $46.91 with a P/E ratio of 23.96x and P/B of 2.87x.

ROE is 12.60% and operating margin is 19.78%. Annual revenue is $20.1B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Boston Scientific Corporation (BSX) Stock Forecast 2026 $46.91 — Price, Financials & Analyst Targets | Alpha Lenz